Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperphenylalaninemia in Polish children's population.

B Cabalska, N Duczynska, I Nowaczewska

    Acta Anthropogenetica
    |January 1, 1985
    PubMed
    Summary

    Newborn screening identified 144 hyperphenylalaninemia cases. Most had phenylketonuria (PKU) requiring diet, while others had mild forms managed without treatment, showing normal development.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Different presentations of late-detected phenylketonuria in two brothers with the same R408W/R111X genotype in the PAH gene.

    Journal of intellectual disability research : JIDR·2003
    Same author

    Should newborn mutation scanning for hyperphenylalaninaemia and galactosaemia be implemented? A Polish experience.

    Journal of medical screening·2001
    Same author

    [Standards for diagnosis and treatment of phenylketonuria].

    Medycyna wieku rozwojowego·2001
    Same author

    [Non-ketonic hyperglycinemia].

    Medycyna wieku rozwojowego·2000
    Same author

    [Serum tyrosine in children with phenylketonuria and mild hyperphenylalaninemia].

    Medycyna wieku rozwojowego·2000
    Same author

    [Mutations causing hereditary hyperphenylalaninemia].

    Medycyna wieku rozwojowego·2000

    Area of Science:

    • Biochemistry
    • Genetics
    • Pediatrics

    Background:

    • Hyperphenylalaninemia (HPA) is a metabolic disorder often detected via newborn screening.
    • Early diagnosis and management are crucial for preventing intellectual disability.

    Purpose of the Study:

    • To discuss the differential diagnosis of HPA detected in newborns.
    • To evaluate outcomes for infants diagnosed with phenylketonuria (PKU) and mild HPA.

    Main Methods:

    • Analysis of 144 newborn screening cases for HPA.
    • Diagnostic confirmation using protein loading tests for doubtful cases.
    • Longitudinal monitoring of biochemical markers and developmental scores.

    Main Results:

    • 123 infants were diagnosed with phenylketonuria (PKU) and initiated on a low-phenylalanine diet.
    • 21 infants diagnosed with mild HPA showed decreasing phenylalanine and tyrosine levels with age.
    • Overall normal mental development was observed in the mild HPA group by age 3-7 years.

    Conclusions:

    • Newborn screening effectively identifies HPA, enabling timely intervention for PKU.
    • Mild HPA cases can be managed conservatively with regular monitoring.
    • Further investigation is warranted for the two cases with lower IQs in the mild HPA group.

    Related Experiment Videos